TISSUEBLUE: payments to doctors
Payments that named TISSUEBLUE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $298K
- Providers
- 540
- Transactions
- 989
- Average per transaction
- $301
The per-transaction average — $301 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 540 providers the average total is $552, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Dutch Ophthalmic, USA | $272,237 | 91.4% |
| Dutch Ophthalmic Research Center (international) B.v. | $25,757 | 8.6% |